Renee N. Donahue

National Cancer Institute — United States

Medicine · Health Sciences

41h-index5.7kcitations250works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(125), Immunotherapy and Immune Responses(86), CAR-T cell therapy research(50), Prostate Cancer Treatment and Research(26), Virus-based gene therapy research(25)

Publications250 total

The quadruple immunotherapy for colorectal cancer (QuICC) trial for mismatch repair-proficient metastatic colorectal cancer
The Oncologist·2026Open Access
A phase 2 study of GI-6207 in patients with recurrent medullary thyroid cancer
The Oncologist·2025Open Access
Pembrolizumab in recurrent or metastatic medullary thyroid cancer
The Oncologist·2025Open Access
168 Increases in peripheral memory T cells with self-renewing properties in patients with advanced solid tumors treated with tumor-targeting IL-12 immunocytokine therapy
Regular and Young Investigator Award Abstracts·2025Open Access
37 Early changes in serum proteomic profiles predict anti-tumor activity in patients with advanced HPV-associated malignancies treated with novel combination immunotherapy
Regular and Young Investigator Award Abstracts·2025Open Access
44 Early kinetics of circulating tumor HPV-16 and HPV-18 DNA are associated with survival in patients with HPV-associated cancers treated with dual blockade of PD-L1 and TGF-β
Regular and Young Investigator Award Abstracts·2025Open Access
48 Interrogation of the peripheral immunome from QuEST1 in men with castration-resistant prostate cancer
Regular and Young Investigator Award Abstracts·2025Open Access
169 Impact of a Vβ6/Vβ10 targeting IL-2 fusion protein (invikafusp alfa) on the peripheral immunome, including stimulation of memory T cells with self-renewing properties, in patients with cancer
Regular and Young Investigator Award Abstracts·2025Open Access
47 A tumor-targeting IL-12 immunocytokine therapy in patients with advanced solid tumors increases peripheral natural killer (NK) cells with phenotypes associated with increased tumor cell lysis
Regular and Young Investigator Award Abstracts·2025Open Access
Supplementary Table S4 from Increased Peripheral T Stem Cell–like Memory Features in Patients with Advanced Solid Tumors Treated with Tumor-Targeting IL-12 Immunocytokine Therapy
2025Open Access
Supplementary Table S5 from Increased Peripheral T Stem Cell–like Memory Features in Patients with Advanced Solid Tumors Treated with Tumor-Targeting IL-12 Immunocytokine Therapy
2025Open Access
Supplementary Figure S5 from Increased Peripheral T Stem Cell–like Memory Features in Patients with Advanced Solid Tumors Treated with Tumor-Targeting IL-12 Immunocytokine Therapy
2025Open Access
Supplementary Figure S6 from Increased Peripheral T Stem Cell–like Memory Features in Patients with Advanced Solid Tumors Treated with Tumor-Targeting IL-12 Immunocytokine Therapy
2025Open Access
Data from Increased Peripheral T Stem Cell–like Memory Features in Patients with Advanced Solid Tumors Treated with Tumor-Targeting IL-12 Immunocytokine Therapy
2025Open Access
Supplementary Figure S2 from Increased Peripheral T Stem Cell–like Memory Features in Patients with Advanced Solid Tumors Treated with Tumor-Targeting IL-12 Immunocytokine Therapy
2025Open Access
Supplementary Table S1 from Increased Peripheral T Stem Cell–like Memory Features in Patients with Advanced Solid Tumors Treated with Tumor-Targeting IL-12 Immunocytokine Therapy
2025Open Access
Supplementary Figure S4 from Increased Peripheral T Stem Cell–like Memory Features in Patients with Advanced Solid Tumors Treated with Tumor-Targeting IL-12 Immunocytokine Therapy
2025Open Access
Supplementary Figure S3 from Increased Peripheral T Stem Cell–like Memory Features in Patients with Advanced Solid Tumors Treated with Tumor-Targeting IL-12 Immunocytokine Therapy
2025Open Access
Supplementary Figure S1 from Increased Peripheral T Stem Cell–like Memory Features in Patients with Advanced Solid Tumors Treated with Tumor-Targeting IL-12 Immunocytokine Therapy
2025Open Access
Supplementary Table S2 from Increased Peripheral T Stem Cell–like Memory Features in Patients with Advanced Solid Tumors Treated with Tumor-Targeting IL-12 Immunocytokine Therapy
2025Open Access
page 1 of 13Next →

Frequent Co-authors

Jeffrey Schlom(35), James L. Gulley(28), Ravi A. Madan(23), Christopher R. Heery(18), Jennifer L. Marté(18), Italia Grenga(15), Caroline Jochéms(14), Marijo Bilušić(13), Julius Strauss(12), Lisa M. Cordes(11), Lauren M. Lepone(11), Ian S. Zagon(10), Patricia J. McLaughlin(10), Fatima Karzai(9), Seth M. Steinberg(8), Claudia Palena(8), James W. Hodge(8), William L. Dahut(6), Margaret E. Gatti‐Mays(6), Benedetto Farsaci(6)